Latest Regulatory News

Australian Unity Limited has agreed to acquire Plena Healthcare for $70 million, significantly scaling its Home Health services and workforce. The move aims to create one of Australia's leading integrated healthcare providers, pending regulatory approval.

Nanoveu Limited has completed a $2 million capital raise through a strategic placement and exercised options, reinforcing its position in advanced semiconductor and 3D visualization technologies.

Broken Hill Mines Limited will have its trading suspension lifted on 21 July 2025, marking its return to the ASX following successful compliance with listing rules.

Yancoal Australia is set to increase its ownership in the Moolarben Joint Venture from 95% to 98.75% through a $110.5 million acquisition, combining upfront and deferred payments linked to coal prices.

Rincon Resources Limited has announced a non-renounceable entitlement offer to issue options aimed at raising approximately $97,520, fully underwritten by Golden Triangle Capital Pty Ltd. The offer may lead to a 25% dilution if all options are exercised.

Yugo Metals Limited has launched a $100,000 capital raising through a new options offer, aiming to bolster working capital while navigating significant geopolitical and operational challenges in Bosnia and Herzegovina.

Strickland Metals plans a capital return by distributing 1.2 billion Gateway Convertible Preference Shares to its shareholders, significantly reducing its stake and reshaping ownership. The move awaits shareholder approval and hinges on conditions tied to an asset sale agreement.

Magnetic Resources NL has reported a significant 22% increase in gold resources at its Lady Julie Gold Project, now containing over 2.14 million ounces, while securing a key Native Title Agreement that clears the path for mining leases and development.

TAL Dai-ichi Life Australia has obtained all necessary regulatory approvals, including from APRA, to finalize its minority investment in Challenger Limited, acquiring a 19.9% equity stake.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

DigitalX has expanded its Bitcoin treasury by acquiring an additional 57.5 BTC, pushing total holdings to over 425 BTC valued at A$78.2 million. This move underscores the company’s commitment to a Bitcoin-first strategy amid growing institutional interest.

G50 Corp Limited attributes its recent share price jump to earlier announcements about a new precious metals discovery, confirming no undisclosed information is driving the trading activity.